BRCA2 antibody (AA 2913-3151)
-
- Target See all BRCA2 Antibodies
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Binding Specificity
- AA 2913-3151
-
Reactivity
- Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BRCA2 antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- Specificity
- The antibody is a rabbit polyclonal antibody raised against BRCA2. It has been selected for its ability to recognize BRCA2 in immunohistochemical staining and western blotting.
- Purification
- Antigen-specific affinity chromatography
- Immunogen
- BRCA2 (Ala2913-Pro3151)
- Isotype
- IgG
- Top Product
- Discover our top product BRCA2 Primary Antibody
-
-
- Application Notes
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- Comment
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
- Target
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
- Alternative Name
- Breast Cancer Susceptibility Protein 2 (BRCA2) (BRCA2 Products)
- Background
- Alternative Names: BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast Cancer 2,Early Onset, Breast Cancer Type 2 Susceptibility Protein, Fanconi anemia group D1 protein
- Pathways
- DNA Damage Repair, M Phase, Maintenance of Protein Location
-